Adjuvant Capecitabine in Triple-Negative Breast Cancer: New Strategies for Tailoring Treatment Recommendations

JAMA. 2021 Jan 5;325(1):36-38. doi: 10.1001/jama.2020.23371.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Breast Neoplasms* / drug therapy
  • Capecitabine / therapeutic use
  • Chemotherapy, Adjuvant
  • Disease-Free Survival
  • Humans
  • Maintenance
  • Triple Negative Breast Neoplasms* / drug therapy

Substances

  • Capecitabine